Compactable oral formulations of ibutamoren
US12390452B2 · kind B2 · utility
0Cited by
6References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2024 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Apr 4, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to pharmaceutical solid forms and pharmaceutical compositions comprising ibutamoren or a pharmaceutically acceptable salt thereof, and methods for administering to a pediatric subject for treating growth hormone deficiency.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.